Exact Mass: 305.0051352

Exact Mass Matches: 305.0051352

Found 34 metabolites which its exact mass value is equals to given mass value 305.0051352, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Isoimide

N-(Bromophenyl)-3,4,5,6-tetrahydroisophthalimide

C14H12BrNO2 (305.0051352)


   

Imide

N-(4-Bromophenyl)-3,4,5,6-tetrahydrophthalimide

C14H12BrNO2 (305.0051352)


   
   

10H-Phenothiazine,3,7-dinitro-, 5-oxide

10H-Phenothiazine,3,7-dinitro-, 5-oxide

C12H7N3O5S (305.0106412)


   

4-Bromo-2-methoxy-N-phenylbenzamide

4-Bromo-2-methoxy-N-phenylbenzamide

C14H12BrNO2 (305.0051352)


   

2-[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]aniline

2-[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]aniline

C14H9Cl2N3O (305.0122644)


   

3-Bromo-N-(tert-butyl)-5-methylbenzenesulfonamide

3-Bromo-N-(tert-butyl)-5-methylbenzenesulfonamide

C11H16BrNO2S (305.00850560000003)


   
   

BENZYL 4-BROMOPHENYLCARBAMATE

BENZYL 4-BROMOPHENYLCARBAMATE

C14H12BrNO2 (305.0051352)


   

ETHYL 3-(5-BROMO-2-METHYL-4-NITRO-1H-IMIDAZOL-1-YL)PROPANOATE

ETHYL 3-(5-BROMO-2-METHYL-4-NITRO-1H-IMIDAZOL-1-YL)PROPANOATE

C9H12BrN3O4 (305.00111319999996)


   

N-CHLOROACETYL-3,5-BIS(TRIFLUOROMETHYL)ANILINE

N-CHLOROACETYL-3,5-BIS(TRIFLUOROMETHYL)ANILINE

C10H6ClF6NO (305.0042088)


   

n-t-butyl 3-bromo-4-methylbenzenesulfonamide

n-t-butyl 3-bromo-4-methylbenzenesulfonamide

C11H16BrNO2S (305.00850560000003)


   

N-(4-bromophenyl)-4-methoxy-benzamide

N-(4-bromophenyl)-4-methoxy-benzamide

C14H12BrNO2 (305.0051352)


   

7-BROMO-1,2,3,4-TETRAHYDRO-ACRIDINE-9-CARBOXYLICACID

7-BROMO-1,2,3,4-TETRAHYDRO-ACRIDINE-9-CARBOXYLICACID

C14H12BrNO2 (305.0051352)


   
   

4-BROMO-3-METHOXY-N-PHENYLBENZAMIDE

4-BROMO-3-METHOXY-N-PHENYLBENZAMIDE

C14H12BrNO2 (305.0051352)


   

ETHYL 2-CHLORO-2-(2-(4-CHLORO-2-NITROPHENYL)HYDRAZONO)ACETATE

ETHYL 2-CHLORO-2-(2-(4-CHLORO-2-NITROPHENYL)HYDRAZONO)ACETATE

C10H9Cl2N3O4 (304.99700939999997)


   

3-(6-Bromopyridin-2-yl)-4-methyl-benzoic acid methyl ester

3-(6-Bromopyridin-2-yl)-4-methyl-benzoic acid methyl ester

C14H12BrNO2 (305.0051352)


   

[2-(5-BROMO-THIOPHEN-2-YL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER

[2-(5-BROMO-THIOPHEN-2-YL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER

C11H16BrNO2S (305.00850560000003)


   

Benzyl 2-amino-5-bromobenzoate

Benzyl 2-amino-5-bromobenzoate

C14H12BrNO2 (305.0051352)


   

5-bromo-N-(tert-butyl)-2-Methylbenzenesulfonamide

5-bromo-N-(tert-butyl)-2-Methylbenzenesulfonamide

C11H16BrNO2S (305.00850560000003)


   

2-(4-Chloro-3-nitrobenzoyl)benzoic acid

2-(4-Chloro-3-nitrobenzoyl)benzoic acid

C14H8ClNO5 (305.0090988)


   

3-Bromo-N-butyl-5-methylbenzenesulfonamide

3-Bromo-N-butyl-5-methylbenzenesulfonamide

C11H16BrNO2S (305.00850560000003)


   

3-Bromo-N-(tert-butyl)-N-methylbenzenesulfonamide

3-Bromo-N-(tert-butyl)-N-methylbenzenesulfonamide

C11H16BrNO2S (305.00850560000003)


   

4-Bromo-N-(tert-butyl)-3-methylbenzenesulfonamide

4-Bromo-N-(tert-butyl)-3-methylbenzenesulfonamide

C11H16BrNO2S (305.00850560000003)


   
   

3-bromo-N,N-diethyl-4-methylbenzenesulfonamide

3-bromo-N,N-diethyl-4-methylbenzenesulfonamide

C11H16BrNO2S (305.00850560000003)


   

3-Bromo-N,N-diethyl-5-methylbenzenesulfonamide

3-Bromo-N,N-diethyl-5-methylbenzenesulfonamide

C11H16BrNO2S (305.00850560000003)


   

4-Bromo-N,N-diethyl-3-methylbenzenesulfonamide

4-Bromo-N,N-diethyl-3-methylbenzenesulfonamide

C11H16BrNO2S (305.00850560000003)


   

N-BUTYL 3-BROMO-4-METHYLBENZENESULFONAMIDE

N-BUTYL 3-BROMO-4-METHYLBENZENESULFONAMIDE

C11H16BrNO2S (305.00850560000003)


   
   

7-Nitro-9-oxo-9H-fluorene-2-sulfonic acid

7-Nitro-9-oxo-9H-fluorene-2-sulfonic acid

C13H7NO6S (304.99940820000006)


   

2-bromo-N-(3-methoxyphenyl)benzamide

2-bromo-N-(3-methoxyphenyl)benzamide

C14H12BrNO2 (305.0051352)


   

Taminadenant

Taminadenant

C10H8BrN7 (305.0024508)


Taminadenant (NIR178; PBF509) is a highly potent and orally active adenosine A2A receptor (A2AR) antagonist. Taminadenant can antagonize A2AR agonist-mediated cAMP accumulation and impedance responses with KB values of 72.8 nM and 8.2 nM, respectively. Taminadenant reverses motor impairments in several rat models of movement disorders, including catalepsy, tremor, and hemiparkinsonism. Taminadenant can also inhibit tumor growth when combined with Spartalizumab (HY-P9972). Taminadenant reactivate the antitumor immune response[1][2].